1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Colorectal Cancer Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Colorectal Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Colorectal Cancer Diagnostics Market Regional Analysis
6.2 Europe Colorectal Cancer Diagnostics Market Revenue 2021-2028 (US$ Million)
6.3 Europe Colorectal Cancer Diagnostics Market Forecast Analysis
7. Europe Colorectal Cancer Diagnostics Market Analysis – by Modality
7.1 Imaging Tests
- 7.1.1 Overview
- 7.1.2 Imaging Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.2 Stool-Based Tests
- 7.2.1 Overview
- 7.2.2 Stool-Based Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast, 2021-2028 (US$ Million)
8. Europe Colorectal Cancer Diagnostics Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.2 Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Diagnostic Laboratories: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.3 Cancer Research Institutes
- 8.3.1 Overview
- 8.3.2 Cancer Research Institutes: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast, 2021-2028 (US$ Million)
9. Europe Colorectal Cancer Diagnostics Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Colorectal Cancer Diagnostics Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 9.2.1.1 Europe Colorectal Cancer Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 UK: Europe Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.2.1.1.2 UK: Europe Colorectal Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.2 Germany:
Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Germany: Europe Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.2.1.2.2 Germany: Europe Colorectal Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.3 France:
Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 France: Europe Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.2.1.3.2 France: Europe Colorectal Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.4 Russia:
Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Russia: Europe Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.2.1.4.2 Russia: Europe Colorectal Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.5 Italy:
Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Italy: Europe Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.2.1.5.2 Italy: Europe Colorectal Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.6 Rest of Europe:
Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.2.1.6.2 Rest of Europe: Europe Colorectal Cancer Diagnostics Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Bruker Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Eiken Chemical Co., Ltd.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Epigenomics AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 F. Hoffmann-La Roche Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Illumina Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medtronic Plc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Novigenix SA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Quest Diagnostics Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Siemens Healthineers AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Colorectal Cancer Diagnostics Market
